Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sara Bulfamante"'
Autor:
Silvia Brugiapaglia, Sara Bulfamante, Claudia Curcio, Maddalena Arigoni, Raffaele Calogero, Lisa Bonello, Elisa Genuardi, Rosella Spadi, Maria Antonietta Satolli, Donata Campra, Daniele Giordano, Paola Cappello, Francesca Cordero, Francesco Novelli
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionPancreatic Ductal Adenocarcinoma (PDA) is one of the most aggressive malignancies with a 5-year survival rate of 13%. Less than 20% of patients have a resectable tumor at diagnosis due to the lack of distinctive symptoms and reliable biom
Externí odkaz:
https://doaj.org/article/76a09af1172e4c0f8aa82fe17684894b
Autor:
Einar Birkeland, Giulio Ferrero, Barbara Pardini, Sinan U. Umu, Sonia Tarallo, Sara Bulfamante, Geir Hoff, Carlo Senore, Trine B Rounge, Alessio Naccarati
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-7 (2023)
Abstract Fecal microRNAs represent promising molecules with potential clinical interest as non-invasive diagnostic and prognostic biomarkers. Colorectal cancer (CRC) screening based on the fecal immunochemical test (FIT) is an effective tool for prev
Externí odkaz:
https://doaj.org/article/5d377c62ad044a339f559ffcc1c5b51a
Autor:
Paola Cappello, Francesco Novelli, Giorgia Mandili, Claudia Curcio, Sara Bulfamante, Laura Follia, Giulio Ferrero, Emanuela Mazza, Moitza Principe, Francesca Cordero, Maria Antonietta Satolli, Rosella Spadi, Andrea Evangelista, Daniele Giordano, Duy Viet
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Pancreatic ductal adenocarcinoma (PDA) is an almost incurable tumor that is mostly resistant to chemotherapy (CT). Adaptive immune responses to tumor-associated antigens (TAA) have been reported, but immunotherapy (IT) clinical trials have
Externí odkaz:
https://doaj.org/article/f1f39e8305ee4d40b27f560edc1298f6
Autor:
Moitza Principe, Simone Borgoni, Mariafrancesca Cascione, Michelle Samuel Chattaragada, Sammy Ferri-Borgogno, Michela Capello, Sara Bulfamante, Jennifer Chapelle, Francesca Di Modugno, Paola Defilippi, Paola Nisticò, Paola Cappello, Chiara Riganti, Stefano Leporatti, Francesco Novelli
Publikováno v:
Journal of Hematology & Oncology, Vol 10, Iss 1, Pp 1-13 (2017)
Abstract Background We have previously shown that in pancreatic ductal adenocarcinoma (PDA) cells, the glycolytic enzyme alpha-enolase (ENO1) also acts as a plasminogen receptor and promotes invasion and metastasis formation. Moreover, ENO1 silencing
Externí odkaz:
https://doaj.org/article/fdfdff63e09d4d67b093c8b4ac4b6767
Autor:
Claudia Curcio, Silvia Brugiapaglia, Sara Bulfamante, Laura Follia, Paola Cappello, Francesco Novelli
Publikováno v:
Molecules, Vol 26, Iss 6, p 1642 (2021)
Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal forms of human cancer, characterized by unrestrained progression, invasiveness and treatment resistance. To date, there are limited curative options, with surgical resection as the only
Externí odkaz:
https://doaj.org/article/0b8030c993074ba4898765ed188e8211
Autor:
Einar Birkeland, Giulio Ferrero, Barbara Pardini, Sinan U. Umu, Sonia Tarallo, Sara Bulfamante, Geir Hoff, Carlo Senore, Trine B Rounge, Alessio Naccarati
Faecal microRNAs represent promising molecules with potential clinical interest as non-invasive diagnostic and prognostic biomarkers for their stability and detectability. Colorectal cancer (CRC) screening based on the fecal immunochemical test (FIT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6453af4653c2589018697087ffe23f78
https://doi.org/10.1101/2023.05.03.23289251
https://doi.org/10.1101/2023.05.03.23289251
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 2435
Antibodies against autologous tumor-associated antigens have been demonstrated as being useful biomarkers for early cancer diagnosis and prognosis. They have several advantages such as long half-life (7-30 days depending on subtiter of Ig), inherent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e2e15913315ff2aeedcdbb0b4a9c4b8a
https://pubmed.ncbi.nlm.nih.gov/34993937
https://pubmed.ncbi.nlm.nih.gov/34993937
Autor:
Laura Follia, Claudia Curcio, Paola Cappello, Silvia Brugiapaglia, Francesco Novelli, Sara Bulfamante
Publikováno v:
Molecules, Vol 26, Iss 1642, p 1642 (2021)
Molecules
Molecules
Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal forms of human cancer, characterized by unrestrained progression, invasiveness and treatment resistance. To date, there are limited curative options, with surgical resection as the only
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78aa3a1eca9ab59f433199c09922ed3e
http://hdl.handle.net/2318/1790633
http://hdl.handle.net/2318/1790633
Autor:
Francesco Novelli, Claudia Curcio, Cecilia Roux, Laura Conti, Roberta Curto, Gianluca Mucciolo, Sara Bulfamante, Silvia Brugiapaglia, Alessandro Scagliotti, Alessandra Ghigo, Paola Cappello, Emilio Hirsch
Publikováno v:
Regular and young investigator award abstracts.
Background Pancreatic ductal adenocarcinoma (PDA) is the 4th leading cause of cancer mortality in developed countries, with one of the poorest prognoses among all cancers. Although 10–15% of patients are candidates for gross total surgical resectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ff2accfbcc02f832554542f645f94c7
https://doi.org/10.1136/jitc-2020-sitc2020.0471
https://doi.org/10.1136/jitc-2020-sitc2020.0471
Publikováno v:
Scopus-Elsevier
Alpha-enolase (ENO1) is a metabolic enzyme involved in the synthesis of pyruvate. It also acts as a plasminogen receptor and mediates the activation of plasmin and extracellular matrix degradation. In tumor cells, ENO1 is up-regulated and supports th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ebb7ba26ca41a9cf71ba1aad4ed772a
https://doi.org/10.2741/4526
https://doi.org/10.2741/4526